Webinars

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Navitus 2022 Drug Trend Report Insights

Access the Drug Trend Report
  • An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

  • Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

  • Achieving Outstanding Results with Tailored Network Strategies

  • Breaking Through Barriers with Value-Based Plan Design

  • Finding a Solution to Lower Prescription Drug Costs

  • Empowered by Strategic Opportunities and Service Excellence

  • QALYiQ Program Delivers Significant Savings for Both Members and Health Plans

  • RISE: Reporting and Intervention for Stars Excellence

  • Medication Therapy Management: Improving Health Outcomes and Reducing Cost

  • Personalized Member Transitions: Creating a Smoother Benefit Transition

  • Pharmacy and Practitioner Exclusions and How to Resolve Them

  • Rx Money Saving Tips

  • Fraud, Waste, and Abuse

  • Participating Pharmacy Network Listing – National and Regional Chains/Groups

  • Prior Authorization

  • Eddie’s Story

  • Wrapping up 2018 and Looking Forward to the New Year

  • Surescripts Prescription Price Transparency Tool Realizes Massive Provider Adoption, Achieves Break

Beware of Groups Posing as Navitus
This is default text for notification bar